Piśmiennictwo

1. Lohmann K, Klein C. Genetics of Dystonia: What’s Known? What’s new? What’s Next? Mov Dis 2013; 28: 899-905.

2. Oppenheim H. UbereineeigenartigeKrampfkrankheit des kindlichen und jugendlichen Alters (dysbasialordoticaprogresisiva, Dystonia musculorumdeformans). NeurolCentralbl 1911; 30: 1090-1107.

3. EldrigeR .Torsion spasm in Jewish children, and the early history of human genetics. Adv Neurol 1976; 14: 105-114.

4. Ichinose H, Ohye T, Takahashi E, at al. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet 1994; 8: 236-242.

5. Albanese A, Asmus F, Bhatia KP, at al. EFNS guidelines on diagnosis and treatment of primary dystonias. Eur J Neurol 2011; 18: 5-18.

6. Balint B, Bhatia KP. Dystonia: an update on phenomenology, classification, pathogenesis and treatment.Curr Opin Neurol 2014; 27: 468-476.

7. Ozelius LJ, Hewett JW, Page CE, at al. The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat Genet 1997; 17: 40-48.

8. Bressman SB, de Leon D, Brin MF at al. Idiopathic dystonia among Ashkenazi Jews: evidence for autosomal dominant inheritance. Ann Neurol 1989; 26: 612-620.

9. Kakazu Y, Koh JY, Ho KW, et al.Synaptic vesicle recycling is enhanced by torsinA that harbors the DYT1 dystonia mutation. Synapse 2012; 66: 453-464.

10. Goodchild RE, Dauer WT. The AAA+ protein torsinA interacts with a conserved domain present in LAP1 and a novel ER protein. J Cell Biol 2005; 168: 855-862.

11. Goodchild RE, Kim CE, Dauer WT. Loss of the dystonia-associated protein torsinA selectively disrupts the neuronal nuclear envelope. Neuron 2005; 48: 923-932.

12. Gordon KL, Gonzalez-Alegre P. Consequences of the DYT1 mutation on torsinAoligomerization and degradation. Neuroscience 2008; 157: 588-595.

13. Cheng FB, Wan XH, Zhang Y, at al.TOR1A sequence variants and the association with early-onset primary dystonia in the Chinese Han population. Parkinsonism Relat Disord 2013; 9: 399-401.

14. Calakos N, Patel VD, Gottron M, at al. Functional evidence implicating a novel TOR1A mutation in idiopathic, late-onset focal dystonia. J Med Genet 2010; 47: 646-650.

15. Zirn B, Grundmann K, Huppke P, at al. Novel TOR1A mutation p.Arg288Gln in early-onset dystonia (DYT1). J NeurolNeurosurg Psychiatry 2008; 79: 1327-1330.

16. Leung JC, Klein C, Friedman J, at al. Novel mutation in the TOR1A (DYT1) gene in atypical early onset dystonia and polymorphisms in dystonia and early onset parkinsonism. Neurogenetics 2001; 3: 133-143.

17. Parker N. Hereditary whispering dysphonia. J NeurolNeurosurg Psychiatry 1985; 48: 218-224.

18. Hersheson J, Mencacci NE, Davis M. Mutation in the Autoregulatory Domain of β-Tubulin 4a Cause Hereditary Dystonia. Ann Neurol 2013; 73: 546-553.

19. Yen TJ, Gay DA, Pachter JS, at al. Autoregulated changes in stability of polyribosome-bound beta-tubulin mRNAs are specified by the first 13 translated nucleotides. Mol Cell Biol 1988; 8: 1224-1235.

20. Fuchs T, Gavarini S, Saunders-Pullman R, at al. Mutations in the THAP1 gene are responsible for DYT6 primary torsion dystonia. Nat Genet 2009; 41: 286-288.

21. Zhao Y, Xiao J, Gong S, et al. Neural expression of the transcription factor THAP1 during development in rat. Neuroscience 2013; 231: 282-295.

22. Xiao J, Uitti RJ, Zhao Y, at al. Mutations in CIZ1 cause adult onset primary cervical dystonia. Ann Neurol 2012; 71: 458-469.

23. Klein C, König IR, Lohmann K. Exome sequencing for gene discovery: time to set standard criteria. Ann Neurol 2012; 72: 627-628.

24. Charlesworth G, Plagnol V, Holmstrom KM, at al. Mutations in ANO3 cause dominant craniocervical dystonia: ion channel implicated in pathogenesis. Am J Hum Genet 2012; 91: 1041-1050.

25. Fuchs T, Saunders-Pullman R, Masuho I, at al. Mutations in GNAL cause primary torsion dystonia. Nat Genet 2012; 45: 88-92.

26. Zhuang X, Belluscio L, Hen R. G(olf)alpha mediates dopamine D1 receptor signaling. J Neurosci 2000; 20: RC91.

27. Fadool DA, Estey SJ, Ache BW. Evidence that a Gq-protein mediates excitatory odor transduction in lobster olfactory receptor neurons. Chem Senses 1995; 20: 489-498.

28. Evidente VG. Zolpidem improves dystonia in “Lubag” or X-linked dystonia-parkinsonism syndrome. Neurology 2002; 58: 662-663.

29. Kupke KG, Lee LV, Viterbo GH at al. X-linked recessive torsion dystonia in the Philippines. Am J Med Genet 1990; 36: 237-242.

30. Muller U. The monogenic primary dystonias. Brain 2009; 132: 2005-2025.

31. Zimprich A, Grabowski M, Asmus F, at al. Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. Nat Genet 2001; 29: 66-69.

32. Roze E, Apartis E, Clot F, at al. Myoclonus-dystonia: clinical and electrophysiologic pattern related to SGCE mutations. Neurology 2008; 70: 1010-1016.

33. Chan P, Gonzalez-Maeso J, Ruf F, at al. Epsilon-sarcoglycan immunoreactivity and mRNA expression in mouse brain. J Comp Neurol 2005; 482: 50-73.

34. Esapa CT, Waite A, Locke M, at al. SGCE missense mutations that cause myoclonus-dystonia syndrome impair epsilon-sarcoglycan trafficking to the plasma membrane: modulation by ubiquitination and torsinA. Hum Mol Genet 2007; 16: 327-342.

35. Guettard E, Portnoi MF, Lohmann-Hedrich K, at al. Myoclonus-dystonia due to maternal uniparental disomy. Arch Neurol 2008; 65: 1380-1385.

36. Grabowski M, Zimprich A, Lorenz-Depiereux B, at al. The epsilon-sarcoglycan gene (SGCE), mutated in myoclonus-dystonia syndrome, is maternally imprinted. Eur J Hum Genet 2003; 11: 138-144.

37. Brashear A, Deleon D, Bressman SB, at al. Rapid-onset dystonia-parkinsonism in a second family. Neurology 1997; 48: 1066-1069.

38. deCarvalhoAguiar P, Sweadner KJ, Penniston JT, at al. Mutations in the Na+/K+ -ATPase alpha3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism. Neuron 2004; 43: 169-175.

39. Rodacker V, Toustrup-Jensen M, Vilsen B. Mutations Phe785Leu and Thr618Met in Na+, K+-ATPase, associated with familial rapid-onset dystonia parkinsonism, interfere with Na+ interaction by distinct mechanisms. J BiolChem 2006; 281: 18539-18548.

40. Heinzen EL, Swoboda KJ, Hitomi Y, at al. ATP1A3 cause alternating hemiplegia of childhood. Nat Genet 2012; 44: 1030-1034.

41. Camargos S, Scholz S, Simon-Sanchez J, at al. DYT16, a novel young-onset dystonia-parkinsonism disorder: identification of a segregating mutation in the stress-response protein PRKRA. Lancet Neurol 2008; 7: 207-215.

42. Patel CV, Handy I, Goldsmith T, at al. PACT, a stress-modulated cellular activator of interferon-induced double-stranded RNA-activated protein kinase, PKR. J Biol Chem 2000; 275: 37993-37998.

43. Segawa M, Nomura Y, Nishiyama N. Autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (Segawa disease). Ann Neurol 2003; 54 (Suppl 60: S32-45.

44. Ichinose H, Ohye T, Takahashi E, at al. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet 1994; 8: 236-242.

45. Bartholomé K, Lüdecke B. Mutations in the tyrosine hydroxylase gene cause various forms of L-dopa-responsive dystonia. Adv Pharmacol 1998; 42: 48-49.

46. Zhou QY, Quaife CJ, Palmiter RD. Targeted disruption of the tyrosine hydroxylase gene reveals that catecholamines are required for mouse fetal development. Nature1995; 374: 640-643.

47. Bonafe L, Thony B, Penzien JM, at al. Mutations in the sepiapterin reductase gene cause a novel tetrahydrobiopterin-dependent monoamine-neurotransmitter deficiency without hyperphenylalaninemia. Am J Hum Genet 2001; 69: 269-277.

48. Steinberger D, Blau N, Goriuonov D, at al. Heterozygous mutation in 5'-untranslated region of sepiapterinreductase gene (SPR) in a patient with dopa-responsive dystonia. Neurogenetics 2004; 5: 187-190.

49. Suls A, Dedeken P, Goffin K, at al. Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1. Brain 2008; 131: 1831-1844.

50. Bruno MK, Lee HY, Auburger GW, at al. Genotype-phenotype correlation of paroxysmal nonkinesigenic dyskinesia. Neurology 2007; 68: 1782-1789.

51. Lee HY, Xu Y, Huang Y, at al. The gene for paroxysmal non-kinesigenic dyskinesia encodes an enzyme in a stress response pathway. Hum Mol Genet 2004; 13: 3161-170.

52. Chen WJ, Lin Y, Xiong ZQ, at al. Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia. Nat Genet 2011; 43: 1252-1255.

53. Lee HY, Huang Y, Bruneau N, at al. Mutations in the novel protein PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions. Cell Rep 2012; 1: 2-12.

54. Weber YG, Storch A, Wuttke TV, at al. GLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a cation leak. J Clin Invest 2008; 118: 2157-2168.

55. Leen WG, Klepper J, Verbeek MM, at al. Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder. Brain 2010; 133: 655-670.

56. Brocnmann K. The expanding phenotype of GLUT-1deficiency syndrome. Brain Dev 2009; 31: 545-553.

57. Pascual JM, Wang D, Lecumberri B. GLUT1 deficiency and other glucose transporter diseases. Eur J Endocrinol 2004;150:627-633.

58. Herzfeld T, Nolte D, Müller U. Structural and functional analysis of the human TAF1/DYT3 multiple transcript system. Mamm Genome 2007; 18: 787-795.

59. Lee HY, Xu Y, Huang Y, at al. The gene for paroxysmal non-kinesigenic dyskinesia encodes an enzyme in a stress response pathway. Hum Mol Genet 2004; 13: 3161-3170.

60. Stelzl U, Worm U, Lalowski M, at al. A human protein-protein interaction network: a resource for annotating the proteome. Cell 2005; 122: 957-68.

61. Cif L, Valente EM, Hemm S, at al. Deep brain stimulation in myoclonus-dystonia syndrome. Mov Disord 2004; 19: 724-727.

62. Steinberger D, Korinthenberg R, Topka H, at al. Dopa-responsive dystonia: mutation analysis of GCH1 and analysis of therapeutic doses of L-dopa. German Dystonia Study Group. Neurology 2000; 55: 1735-1737.

63. Weber YG, Storch A, Wuttke TV, at al. GLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a cation leak. J Clin Invest 2008; 118: 2157-2168.

64. Coubes P, Vayssiere N, El Fertit H, at al. Deep brain stimulation for dystonia. Surgical technique. Stereotact Funct Neurosurg 2002; 78: 183-191.